These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 32507683)
1. Prevalence and disparities in opioid overdose response training among people who inject drugs, San Francisco: Naloxone training among injectors in San Francisco. Kim K; Oh H; Miller D; Veloso D; Lin J; McFarland W Int J Drug Policy; 2021 Apr; 90():102778. PubMed ID: 32507683 [TBL] [Abstract][Full Text] [Related]
2. Fentanyl self-testing in a community-based sample of people who inject drugs, San Francisco. Oh H; Kim K; Miller D; Veloso D; Lin J; McFarland W Int J Drug Policy; 2020 Aug; 82():102787. PubMed ID: 32516685 [TBL] [Abstract][Full Text] [Related]
3. The naloxone delivery cascade: Identifying disparities in access to naloxone among people who inject drugs in Los Angeles and San Francisco, CA. Kinnard EN; Bluthenthal RN; Kral AH; Wenger LD; Lambdin BH Drug Alcohol Depend; 2021 Aug; 225():108759. PubMed ID: 34058540 [TBL] [Abstract][Full Text] [Related]
4. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018. Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642 [No Abstract] [Full Text] [Related]
5. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs. Reed M; Wagner KD; Tran NK; Brady KA; Shinefeld J; Roth A Int J Drug Policy; 2019 Nov; 73():32-35. PubMed ID: 31336291 [TBL] [Abstract][Full Text] [Related]
6. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland. Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244 [TBL] [Abstract][Full Text] [Related]
7. Perception and Correlates of Opioid Overdose Risk Among Overdose Survivors Who Use Nonprescribed Opioids in San Francisco and Boston. Chang YG; McMahan VM; Marti XL; Pope E; Wolfe S; Majeski A; Reed G; Walley AY; Coffin PO Subst Use Addctn J; 2024 Oct; 45(4):559-567. PubMed ID: 38456483 [TBL] [Abstract][Full Text] [Related]
8. High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study. Bazazi AR; Zelenev A; Fu JJ; Yee I; Kamarulzaman A; Altice FL Int J Drug Policy; 2015 Jul; 26(7):675-81. PubMed ID: 25532449 [TBL] [Abstract][Full Text] [Related]
9. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study. Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J; Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808 [TBL] [Abstract][Full Text] [Related]
10. Intravenous fentanyl use among people who inject drugs in Australia. Geddes L; Iversen J; Memedovic S; Maher L Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465 [TBL] [Abstract][Full Text] [Related]
11. Social mixing and correlates of injection frequency among opioid use partnerships. Rowe C; Santos GM; Raymond HF; Coffin PO Int J Drug Policy; 2017 Mar; 41():80-88. PubMed ID: 28113118 [TBL] [Abstract][Full Text] [Related]
12. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015. Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of multiple non-fatal opioid overdoses among people who inject drugs who utilise needle syringe programs in Australia. Geddes L; Iversen J; Darke S; Dietze P; Maher L Int J Drug Policy; 2021 Oct; 96():103245. PubMed ID: 33840562 [TBL] [Abstract][Full Text] [Related]
14. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland. O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701 [TBL] [Abstract][Full Text] [Related]
15. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700 [TBL] [Abstract][Full Text] [Related]
16. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401 [TBL] [Abstract][Full Text] [Related]
17. Narratives of people who inject drugs on factors contributing to opioid overdose. Chang JS; Behar E; Coffin PO Int J Drug Policy; 2019 Dec; 74():26-32. PubMed ID: 31442677 [TBL] [Abstract][Full Text] [Related]
18. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125 [TBL] [Abstract][Full Text] [Related]
19. Take-home naloxone possession among people who inject drugs in rural West Virginia. Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407 [TBL] [Abstract][Full Text] [Related]
20. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Lambdin BH; Bluthenthal RN; Zibbell JE; Wenger L; Simpson K; Kral AH Int J Drug Policy; 2019 Dec; 74():299-304. PubMed ID: 31733979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]